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Occurrence of potentially zoonotic 
and cephalosporin resistant enteric bacteria 
among shelter dogs in the Central and South-
Central Appalachia
Ashutosh Verma1,2*, Kimberly Carney1,3, Marina Taylor1, Kaitlyn Amsler1, Joey Morgan1, Karen Gruszynski1,3, 
Erdal Erol4, Craig Carter4, Stephan Locke4, Ashton Callipare1 and Devendra H. Shah5* 
Abstract 
Background: Antimicrobial resistance and presence of zoonotic enteropathogens in shelter dogs pose a public 
health risk to shelter workers and potential adopters alike. In this study we investigated the prevalence of zoonotic 
bacterial pathogens and cephalosporin resistant  (CefR) enteric bacteria in the feces of apparently healthy shelter dogs 
in the Cumberland Gap Region (CGR) in the US states of Kentucky, Tennessee and Virginia.
Results: Fecal samples of 59 dogs from 10 shelters in the CGR of Central and South-Central Appalachia were 
screened for the presence of Campylobacter jejuni, Clostridium perfringens, Salmonella and  CefR enteric bacteria. C. 
jejuni, C. perfringens were detected by PCR based assays. Culture and PCR were used for Salmonella detection. Of 59 
dogs, fecal samples from 14 (23.7%) and 8 (13.6%) dogs tested positive for cpa and hipO genes of C. perfringens and C. 
jejuni, respectively. Salmonella was not detected in any of the tested samples by PCR or culture.  CefR enteric bacteria 
were isolated on MacConkey agar supplemented with ceftiofur followed by identification using MALDI-TOF. Fecal 
samples from 16 dogs (27.1%) yielded a total of 18  CefR enteric bacteria. Majority of  CefR isolates (14/18, 77.8%) were E. 
coli followed by, one isolate each of Enterococcus hirae, Acinetobacter baumannii, Acinetobacter pittii, and Pseudomonas 
aeruginosa.  CefR enteric bacteria were tested for resistance against 19- or 24-antibiotic panels using broth microdilu-
tion method. Seventeen (94.4%)  CefR bacteria were resistant to more than one antimicrobial agent, and 14 (77.8%) 
displayed multidrug resistance (MDR).
Conclusions: This study shows that shelter dogs within the CGR not only carry zoonotic bacterial pathogens, but 
also shed multidrug resistant enteric bacteria in their feces that may pose public health risks.
Keywords: Shelter dogs, Central and South-Central Appalachia, Multi-drug resistance (MDR), Antimicrobial resistance 
(AMR)
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Background
Cephalosporin-resistant enteropathogens are prevalent 
worldwide and are a formidable threat to both public 
and animal health as many exhibit multi-drug resist-
ance (MDR) [1]. This is concerning because extended-
spectrum cephalosporins are listed as key antibiotics 
for treatment of bacterial infections in both humans 
and animals [2, 3]. Companion animals can serve as a 
reservoir of anti-microbial resistant (AMR) bacteria 
that have an increased potential for zoonotic transmis-
sion due to their intimate contact with humans [4–7]. 
While previous research on companion animal reser-
voirs for AMR has focused on clinically ill animals [4, 
8, 9], the literature on the fecal analysis of healthy dogs, 
especially shelter dog population in the United States is 
lacking [10]. The 2019-2020 APPA National Pet Own-
ers Survey reported 19% dogs obtained from animal 
shelter/humane society [9, 11]. Thus, monitoring for 
the zoonotic pathogens and the AMR in shelter dogs 
is important for understanding the risk to the human 
population and the environment.
Population of dogs housed in animal shelters are at 
increased risk of carrying and spreading a variety of 
enteric pathogens to both animals and humans. Some 
of the common enteropathogens of dogs are also impor-
tant public health pathogens. For instance, Camylobac-
ter jejuni (C. jejuni) is a zoonotic pathogen frequently 
detected in symptomatic and asymptomatic dogs [12]. A 
few studies have reported that living with diarrheic pets 
is a risk factor for campylobacteriosis in humans [13–20]. 
A recent multi-laboratory survey in the United States 
showed that 1.3% symptomatic and 1.1% asymptomatic 
dogs shed Salmonella in their feces [21]. Similarly, toxin 
producing Clostridium perfringens (cpa-positive C. per-
fringens) is present in diarrheic and healthy dogs and is 
also considered as potential zoonotic pathogen [22].
Some factors that contribute to the introduction, per-
sistence, and spread of enteric pathogens in animal shel-
ters include high animal population densities, lack of 
proper veterinary care, stressful and unsanitary housing 
conditions, limited funding, adoption across state bound-
aries, and high animal turnover [23]. Cultural and socio-
economic factors unique to the Appalachian Region 
further complicate these issues and put these animals at a 
risk of getting infected, becoming carriers, and transmit-
ting diseases to both animals and humans. The objective 
of this study was to detect occurrence of zoonotic enter-
opathogens including C. jejuni, Salmonella, cpa-positive 
C. perfringens and cephalosporin resistant  (CefR) enteric 
bacteria in the feces of dogs (owner surrender, free-roam-
ing, feral) housed in ten animal shelters across three US 




Animal attributes of shelter location, sex (male or 
female), estimated age, and fecal score were recorded at 
the time of sampling (Table 1). The dogs sampled in this 
study included 23 (39%) female, 36 (61%) male, and had a 





Sex Fecal Score Bacterial isolates MALDI
scores
CR01 KR Pit mix 2 f 6 E. coli 2.51
CR02 KR Lab mix 2 m 4 E. coli 2.40
CR03 LC Pitbull 1 m 2 E. coli 2.54
CR04 LC Rottweiler mix 4 m 3 E. coli 2.49
CR05 LC Australian shepherd mix 3 m 2 E. coli 2.33
CR06 UC Collie mix 0.17 m 3 E. coli 2.56
CR07 UC Collie mix 0.3 f 3 E. coli 2.49
CR08 SL Chihuahua 5 m 3 E. coli 2.49
CR09 SL Lab 1.5 m/n 3 E. coli 2.58
CR11 SL Pitbull 3 m 5 E. coli 2.41
CR12 SL Pit/Shepherd mix 1 m 3 E. coliEnterococcus hirae 2.52
2.32
CR13 SL Hound 1 m 3 E. coli 2.33
CR14 JO Beagle mix 3 f 2 Acinetobacter baumannii 2.32




CR16 KW Border Collie 0.42 m 6 E. coli 2.44
CR17 KW Chihuahua mix 2 f 2 E. coli 2.51
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mean age of 2.2 years (range 2 months to 10 years), and a 
mean fecal score of 2.95 (range 1-6; Purina Fecal Scoring 
Scale). A fecal score of 1 indicates a hard and dry stool, 3 
is normal, and a fecal score of 6 is indicative of a watery 
stool with no solid composition.
Occurrence of C. jejuni, C. perfringens and Salmonella 
in shelter dogs
Of the 59 dogs tested in this study, 8 (13.6%; 95% CI: 
6-30%) and 14 (23.7%; 95% CI: 13.6-36.6%) were positive 
for the hipO and cpa genes of C. jejuni and C. perfringens, 
respectively (Fig. 1). Three dogs were positive for both C. 
jejuni and C. perfringens. None of the dogs were positive 
for Salmonella by culture or by PCR methods. Out of 10 
shelters, C. jejuni was detected in fecal samples collected 
from 3 (30%) shelters while cpa-positive C. perfringens 
was detected in fecal samples collected from 7 (70%) 
shelters. C. jejuni was detected most frequently in the 
fecal samples (4/8, 50%) collected from KR shelter. Many 
of the expected counts for chi-square tests were less than 
5 due to the low number of samples and positive results 
except for C. perfringens and sex which was not statisti-
cally significant. Therefore, no statistical interpretation 
can be made regarding the other variables and test results 
for the sampled shelter dogs.
Occurrence of Ceftiofur‑resistant enteric bacteria
MALDI scores of  CefR fecal isolates obtained in this study 
ranged from 2.32 to 2.56, allowing species-specific identi-
fication (Table 1).  CefR resistant enteric bacteria were iso-
lated from six (60%) out of the ten shelters sampled in this 
study. Of the 59 dogs sampled in this study, 16 (27.1%; 
95% CI: 16.4-40.3%) tested positive for carriage of  CefR 
bacteria. These 16 dogs yielded a total of 18  CefR resistant 
enteric bacteria (Table 1). A single/mono culture of  CefR 
E. coli was isolated from 13 out of 16 dogs (81.2%). The 
remaining three dogs (18.8%) yielded a mono culture of 
Acinetobacter baumannii (dog ID: CR14), mixed culture 
Fig. 1 CefR enteric bacteria among shelter dogs. Map depicts the dog shelters in the US states of Kentucky, Tennessee, and Virginia. Fecal samples 
were collected from 8 dogs from Shelter WT, 7 dogs from Shelter KW, 6 dogs each from Shelters KR, BC, CC, LC, UC, SL, JO, and 2 dogs from Shelter 
BR. The proportions of  CefR enteric bacteria within each shelter pie chart is shown. Map created with ArcMap 10.6 (Esri, Redlands, CA)
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of  CefR E. coli and Enterococcus hirae (dog ID: CR12) and 
a mixed culture of Acinetobacter pitii and Pseudomonas 
aeruginosa (dog ID: CR15). Among the  CefR-positive 
dogs, the mean age was 1.9 years (range 2 months to 5 
years), and the mean fecal score was 3 (range 2-6). Of 
note, 5 out of 6 (83.33%) samples from shelter SL dem-
onstrated cephalosporin resistance, accounting for nearly 
32% of all  CefR bacteria isolated in this study. Only the 
variables sex and shelter when analyzed at the state-level 
had any statistical meaning due to small sample size and 
number of positives. State-level analysis showed a sig-
nificant difference (p-value = 0.049) among the three 
states in terms of dogs having  CefR enteric bacteria. At 
the state-level, Tennessee reported 45.8% (11/24; 95% CI: 
25.6-67.2%), followed by Kentucky (4/19, 21.2%; 95% CI: 
6.1-45.6%), and Virginia (2/16, 12.5%; 95% CI: 1.6-38.4%). 
Shelter SL is located within Tennessee which likely influ-
enced the results.
Occurrence of antimicrobial resistance
Antimicrobial susceptibilities of  CefR isolates (n=18) to a 
broad range of antibiotics that are relevant to companion 
animals were tested.  CefR enteric bacteria isolated in this 
study also showed resistance to amoxicillin-clavulanate 
(n=17), ampicillin (n=14), cefazolin (n=18), cefpodox-
ime (n=14), ceftazidime (n=14), chloramphenicol (n=2), 
doxycycline (n=8), gentamicin (n=2), piperacillin (n=2), 
tetracycline (n=9), and trimethoprim/sulfamethoxazole 
(n=3) (Fig. 2).
Seventeen (94.4%)  CefR isolates were resistant to more 
than one antibiotic (Fig. 3). Of the 14 E. coli isolates, 11 
(78.6%) isolates exhibited MDR phenotype (resistance to 
three or more antibiotic classes). All E. coli isolates dem-
onstrated resistance to amoxicillin/clavulanic acid, ampi-
cillin, cefazolin, cefpodoxime, and ceftazidime. Eight out 
of 14 E. coli isolates were resistant to doxycycline; 9/14 
to tetracycline; 3/14 to trimethoprim/sulfamethoxazole, 
2/14 to gentamicin and piperacillin, and 1 to chloram-
phenicol (Fig. 3). One E. coli isolate (CR03) demonstrated 
resistance to 9 of the tested antimicrobials (Fig.  3). Iso-
lates from different dogs within a same shelter had same 
antimicrobial resistance profiles, for example, isolates 
CR06 and CR07 (shelter UC); CR08, CR09, CR11, CR12, 
and CR13 (shelter SL); CR14 and CR15A (shelter JO); 
CR16 and CR17 (shelter KW) (Fig. 3).
Discussion
Zoonotic and MDR enteric bacteria in shelter dogs pose 
a serious animal and public health concern. These dogs 
could serve as a reservoir of infections for other dogs, 
shelter worker or potential adopters. As noted ear-
lier, some antimicrobials, such as extended spectrum 
Fig. 2 Antimicrobial resistance of bacterial isolates
Page 5 of 10Verma et al. BMC Vet Res          (2021) 17:313  
cephalosporins, are listed as critical antibiotics for treat-
ing bacterial infections in both humans and animals [2, 
3]. The occurrence of  CefR enteric bacteria in shelter dogs 
in this study was 27.1% (16/59). These data corroborate 
with a recent study conducted in Ontario, Canada where 
average frequency of fecal carriage of  CefR enteric bacte-
ria in apparently healthy dogs was 26.5% [24].
The approach of initial selection for resistance to the 
third-generation cephalosporin (ceftiofur), has been 
used previously in cattle and poultry [25, 26]. Here, we 
employed similar approach to selectively isolate enteric 
bacteria that are not only resistant to cephalosporins, but 
also resistant to other antibiotic classes. For instance, 11 
out of 14 E. coli isolates recovered in this study displayed 
MDR phenotype. The other common resistances noted 
in these isolates were against classes of antimicrobials 
that have been used for decades: penicillin, sulfonamide, 
aminoglycosides, and tetracycline. These findings are also 
consistent with those of Zhang et al (2018) in their study 
of fecal samples from dog parks and clinical settings.
A statistical association was found between the shel-
ter of provenance and the presence of AMR in feces of 
the sampled dogs. While shelter characteristics were not 
recorded, the authors informally observed the shelters 
while collecting the samples. The shelters varied greatly 
in size, age of construction, training of personnel, stock-
ing density, and overall perception of cleanliness. Inter-
estingly, there were similar resistance profiles present 
within the population of individual shelters. For instance, 
E. coli isolates CR06 and CR07 in shelter UC, E. coli iso-
lates CR08, CR09, CR11, CR12, and CR13 in shelter SL, 
E. coli isolates CR16 and CR17 in shelter KW, and A. bau-
mannii and A. pittii isolates CR14 and CR15A in shelter 
JO had similar resistance profiles. These data suggest 
that dog-to-dog or point source transmission was likely 
occurring via environmental contamination or direct 
contact during socialization, even though the dogs were 
individually housed within each shelter. This provides an 
area for future investigation covering biosecurity, hous-
ing design, education, and disinfection processes to eluci-
date the horizontal transmission of resistant bacteria.
In addition, we found that 8 (13.5%) and 14 (23.7%) 
fecal samples tested in this study were positive for C. 
jejuni and cpa-positive C. perfringens. Both C. jejuni 
Fig. 3 Multi-drug resistance patterns of individual bacterial isolates
Page 6 of 10Verma et al. BMC Vet Res          (2021) 17:313 
and C. perfringens are considered zoonotic pathogens 
[12, 22]. Although likely, it is currently unknown if 
any of these bacteria are transmitted from shelter dogs 
or environment to other dogs or people in proxim-
ity within these shelters. Other research groups have 
demonstrated the potential for transmission of dif-
ferent bacterial pathogens between dogs and humans. 
Recently, 78% of the Staphylococcus spp. isolated from 
healthy dogs were reported to exhibit multi-drug resist-
ance [6, 27]. Guardabassi and colleagues reported that 
46% of pet owners carried the same strain of Staphylo-
coccus pseudintermedius as their dogs with deep pyo-
derma [6]. Similarly, other studies have also reported 
transmission of methilicin-resistant staphylococci from 
companion dogs to people in close proximity [28, 29]. 
Between 2016-2019, CDC reported two MDR Campy-
lobacter outbreaks, which included almost 150 human 
cases, linked to contact with pet store puppies [30]. 
Although Salmonella was not detected in our study, 
zoonotic transmission of Salmonella from dogs to 
human has been reported [31–36]. The carriage and 
potential for transmission of zoonotic bacterial patho-
gens such as Campylobacter between clinically ill com-
panion animals and humans is not a novel concept [19, 
37]. However, this data shows that apparently healthy 
shelter dogs can be carriers of zoonotic and MDR 
enteric bacteria and may pose a hazard for pet own-
ers, an increased occupational risk for animal care and 
veterinary staff, as well as a need for further research 
on this topic. Several bacterial species isolated in this 
study are known opportunistic human pathogens. For 
example, dog feces serve as a potential reservoir for E. 
coli with potential for extraintestinal infections such 
as urinary tract infections in humans [38–40]. The 
pathogen-AMR combinations detected in the current 
study have been identified as significant human path-
ogens under GLASS surveillance [41]. The results of 
interest include E. coli with resistance to penicillins, 
third and fourth generation cephalosporins, sulfona-
mides/trimethoprim. Although Acinetobacter spp. is on 
the GLASS surveillance list, the isolates in this study 
showed resistance only to penicillins and cephalospor-
ins, which are not the antibiotic classes of interest. The 
ecology, epidemiology, and potential public health sig-
nificance of the organisms in this specific situation of 
animal shelters is currently unknown and requires fur-
ther investigation [42, 43].
One of the inherent limitations for this study is the lack 
of medical history for each dog. For example, the prior 
antimicrobial use of these dogs is unknown, as they were 
an undisclosed mix of captured and owner-surrendered 
dogs. It is worthwhile to note that exposure to multi-
ple antimicrobials is not uncommon in many shelter 
situations [44] as upper respiratory (canine infectious 
respiratory disease-CIRD), gastrointestinal and heart-
worm diseases are frequently encountered in shelters. 
Broad-spectrum antibiotics such as doxycycline, may be 
used as part of treatment regimen for the above condi-
tions [45]. Additional antibiotic treatments in shelters 
include amoxicillin-clavulanate, azithromycin, enrofloxa-
cin, and trimethoprim-sulfonamide [46]. These antibiot-
ics can select for multi-drug resistant bacteria within the 
shelter population, which may explain why resistance 
against all of these antibiotics were observed in the iso-
lates in our study. It is possible that use of one or more 
antibiotics may have not only selected for MDR bacteria 
in the dogs screened in this study, but also leading to per-
sistence and potential transmission between dogs.
Conclusions
The results of this study show that shelter dog popula-
tion can serve as a potential reservoir for zoonotic and 
MDR enteric bacteria and raise a possibility transmission 
to humans in proximity. Noting that many shelters allow 
the volunteers and general public to interact freely with 
these animals prior to adoption, the potential risk may 
not be just limited to the shelter staff. In case of vulner-
able groups (geriatric, immunocompromised, undergo-
ing chemotherapy), a screening protocol for zoonotic and 
AMR pathogens prior to adoption may be considered. 
Microbiome diagnostics may be of value in these situa-




This study was conducted on freely voided fecal sam-
ples collected under a protocol that was exempted by 
the Institutional Animal Care and Use Committee at 
the Lincoln Memorial University. Informed consent was 
obtained from the animal shelter directors to collect and 
use the fecal samples for research.
Sample collection
During Summer 2019, fecal samples were collected from 59 
apparently healthy dogs, varying in sex and age, housed in 
10 different shelters in the Appalachian Region of Kentucky, 
Tennessee, and Virginia (Fig. 4). The animals were appar-
ently healthy, of varied ages and sexes at the time of sample 
collection. Fresh fecal samples (9-50 g) were collected from 
freshly voided samples in the individual kennel. Upon col-
lection into plastic zip-top bags, samples were immediately 
placed on ice and transported to the lab for further process-
ing. Demographic information including shelter location, 
animal age, breed, sex, and fecal score (Purina scale) were 
recorded for each dog (Table 1).
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PCR screening for C. jejuni, C. perfringens and Salmonella
Total genomic DNA was extracted from each fecal sam-
ple (n=59) using QIAamp DNA Stool Mini Kit follow-
ing manufacturer’s instructions (Qiagen, Germantown, 
MD). Extracted DNA were quantified and screened for 
detection of C. jejuni, C. perfringens and Salmonella by 
PCR as follows. For the detection of C. jejuni, a PCR tar-
geting hipO gene was used as described previously [47]. 
Each 25 μL PCR reaction contained 1.25 U FastStart Taq 
Polymerase (Roche Diagnostics), 1X PCR buffer (Applied 
Biosystems), 0.2 μM hipO-F (5’ GAC TTC GTG CAG ATA 
TGG ATG CTT ), 0.2 μM hipO-R (5’ GCT ATA ACT ATC 
CGA AGA AGC CAT CA), 5 μL of fecal DNA, and ther-
mal conditions as described previously [47]. For amplifi-
cation of cpa gene from C. perfringens, each 25 μL PCR 
mixture consisted of 12.5 μL of DreamTaq PCR mas-
ter mix (Thermo Fisher Scientific, CA, USA), 0.25 μM 
cpa1F primer (5′-GCT AAT GTT ACT GCC GTT GA-3′), 
0.25 μM cpa1R primer (5′-CCT CTG ATA CAT CGT GTA 
AA-3′), and 1 μL of fecal DNA. The PCR was performed 
following method described previously [48]. PCR prod-
uct size for C. perfringens was 324 bp. For PCR detection 
of Salmonella, a well-conserved Salmonella gene invA 
was targeted, as described previously [48]. Briefly, each 
25 μL reaction consisted of 0.04 μM invA_F primer (5′ 
GTG TCC TTT GGT ATT AAT CC-3′), 0.04 μM invA_R 
(5′-GTC TGA GCA CTT CTT TAA G-3′) primer, 12.5 μL 
of DreamTaq PCR master mix (Thermo Fisher Scientific, 
CA, USA), and 2 μL of fecal DNA. The thermal condi-
tions consisted of 95 °C for 5 min, followed by 39 cycles 
of 20 s at 95 °C, 20 s at 54 °C, 20 s at 72 °C, and a final 
for 5 min at 72 °C. PCR product size for Salmonella was 
250 bp. Positive controls (genomic DNA extracted from 
a reference strain of each tested bacteria) and negative 
control (water) were included during each PCR run. PCR 
amplicons were analyzed by 1.5% agarose gel electropho-
resis under standard conditions and stained by GelGreen 
Nucleic Acid Gel Stain (Biotium, Inc., Fremont, CA).
Isolation of salmonella
For isolation of Salmonella, 1 g of fecal sample was 
resuspended in 10 ml of buffered peptone water (BPW) 
and incubated overnight at 37°C for 24 h. Subsequently, 
10 drops of sample-BPW suspension were transferred 
Fig. 4 PCR identification of C. jejuni and cpa-positive C.perfringens. For C. jejuni identification A: Lanes 1 and 19, C. jejuni genomic DNA; lanes 2 and 
18, 100bp DNA ladder; lanes 3 and 17, no template control; lanes 4, 5, 6, 7, 10, 11, 15 and 16, C. jejuni hipO positive samples; lanes 8, 9, 12, 13 and 14, 
C. jejuni hipO gene negative samples. For C. perfringens identification. Samples in lanes 1-10 and 11-19 were run on the top and bottom halves of the 
same gel, respectively. B: Lanes 1 and 20, C. perfringens genomic DNA; lanes 2 and 19, 100bp DNA ladder; lanes 3 and 18, no template control; lanes 
4, 5, 6, 7, 8, 9, 10, 11, 12, 13 and 14, 15, 16 and 17, C. perfringens cpa gene positive samples. Lane 15 has a faint band. All samples were tested at least 
twice. Samples in lanes 1-10 and 11-20 were run on the top and bottom halves of the same gel, respectively
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to 10 ml of iodine-supplemented tetrathionate broth 
(TTB, Hardy Diagnostics) and incubated at 37°C for 24 
h. Next, 10 μl of sample-TTB suspension was inoculated 
on XLT-4 agar (Hardy Diagnostics) plates and plates were 
incubated at 37°C for up to 24 h. Suspect Salmonella 
colonies were purified by replica plating and stored at 
−80°C in 15% (v/v) phosphate-buffered glycerol.
Isolation of ceftiofur‑resistant enteric bacteria
One gram of fecal sample was resuspended in 5 ml of 
phosphate buffered saline (PBS) and incubated at room 
temperature for 5 min. Fifty and 150 μl of sample were 
transferred onto a MacConkey agar plate supplemented 
with Ceftiofur (8 μg/ml) and evenly spread over the sur-
face of the agar as described previously [25]. The plates 
were then incubated at 37°C for 15 to 18 h. Two to three 
colonies representing a unique colony morphotype were 
selected, transferred to 5 ml LB containing Ceftiofur (8 
μg/ml), mixed well and then incubated again at 37°C for 
15 to 18 h. Following incubation, the cultures were pre-
served in 15% (v/v) glycerol and frozen at -80°C. Approxi-
mately 1 μl of the sample was taken from the frozen 
stock, streaked onto a blood agar plate, and incubated at 
37°C for 15 to 18 h. These plates were used for identifica-
tion and characterization of isolates.
Identification and characterization of isolates
The individual colonies from pure cultures were identi-
fied by MALDI-TOF (Bruker, Billerica, MA) following 
manufacturer’s instructions. The bacteria with scores 
above 2.0 were identified at the species level. The iso-
lates from pure cultures underwent antimicrobial sus-
ceptibility testing by broth microdilution method using 
commercial plates (COMPGN1F and COMPGP1F, Trek 
Sensititer; ThermoFisher Scientific, Grand Island, NY, 
USA) in accordance to the guidelines established by the 
Clinical and Laboratory Standard Institute (CLSI, 2017). 
The concentrations (μg/ml) of the antimicrobials in 
COMPGN1F panel included Amikacin (4 – 32); Amoxi-
cillin / clavulanic acid 2:1 ratio (0.25/0.12 – 8/4); Ampi-
cillin (0.25 – 8); Cefazolin (1 – 32); Cefovecin (0.25 – 8); 
Cefpodoxime (1 – 8); Ceftazidime (4 – 16); Cephalexin 
(0.5 – 16); Chloramphenicol (2 – 32); Doxycycline (0.25 
– 8); Enrofloxacin (0.12 – 4); Gentamicin (0.25 – 8); Imi-
penem (1 – 8); Marbofloxacin (0.12 – 4); Orbifloxacin 
(1 – 8); Piperacillin / tazobactam (8/4 – 64/4); Prado-
floxacin (0.25 – 2); Tetracycline (4 – 16); Trimethoprim/
sulfamethoxazole (0.5/9.5 – 4/76). The concentration 
of antimicrobials in COMPGP1F panel included Ami-
kacin (16 – 32); Amoxicillin / clavulanic acid 2:1 ratio 
(0.25/0.12 – 8/4); Ampicillin (0.25 – 8); Cefazolin (2 – 4); 
Cefovecin (0.06 – 8); Cefpodoxime (2 – 8); Cephalothin 
(2 – 4); Chloramphenicol (8 – 32); Clindamycin (0.5 – 4); 
Doxycycline (0.12 – 0.5); Enrofloxacin (0.25 – 4); Eryth-
romycin (0.25 – 4); Gentamicin (4 – 16); Imipenem 
(1 – 4); Marbofloxacin (1 – 4); Minocycline (0.5 – 2); 
Nitrofurantoin (16 – 64); Oxacillin+2%NaCl (0.25 – 2); 
Penicillin (0.06 – 8); Pradofloxacin (0.25 – 2); Rifampin 
(1 – 2); Tetracycline (0.25 – 1); Trimethoprim/sulfameth-
oxazole (2/38 – 4/76); Vancomycin (1 – 16). S. aureus 
ATCC 29213, Streptococcus pneumoniae ATCC 46619, 
Enterococcus faecalis ATCC 29212, or Escherichia coli 
ATCC 25922 were tested weekly as quality assurance 
to validate the test. The interpretation of antimicrobial 
susceptibilities was based upon the most recent CLSI 
guidelines as provided by the manufacturer. For E. coli, 
the isolate that were resistant to three or more antibiotic 
classes were labeled as MDR following the CDC-NARMS 
guidelines (https:// www. cdc. gov/ narms/ resou rces/ gloss 
ary. html). Because of their intrinsic antibiotic resistance, 
Pseudomonas spp. and Acinetobacter spp. were labeled 
MDR only if they were resistant to two or more of anti-
biotic classes for which they are not known to be intrinsi-
cally resistant (Shah et al., 2019).
Statistical analysis
Statistical analysis was performed using SPSS 26 (IBM, 
New York). Briefly, test results for C. perfringens, C. 
jejuni and  CefR enteric bacteria were compared to vari-
ables: shelter location, age, sex, and fecal score using 
chi-square test or Fisher’s exact test. Breed was not 
included in analysis due to too much variation in data 
collected. Additionally, shelter locations were grouped 
at state-level and dogs were categorized as < 1 year old 
or ≥ 1 year old to improve results of statistical analysis. 
A p-value of <0.05 was considered significant.
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